ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma.


Journal

Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805

Informations de publication

Date de publication:
06 2023
Historique:
received: 23 01 2023
revised: 28 03 2023
accepted: 19 04 2023
medline: 19 5 2023
pubmed: 2 5 2023
entrez: 1 5 2023
Statut: ppublish

Résumé

Despite notable advances made in preoperative staging, unexpected nodal metastases after surgery are still significantly detected. Given the promising role of neoadjuvant targeted treatments, the definition of novel predictive factors of nodal metastases is an extremely important issue. In this study we aim to analyze the upstaging rate in patients with early stage NSCLC without evidence of nodal disease in the preoperative staging who underwent lobectomy and radical lymphadenectomy. Patients who underwent lobectomy and systematic lymphadenectomy for early stage LUAD without evidence of nodal disease at the preoperative staging using NGS analysis for actionable molecular targets evaluation after surgery were evaluated. Exclusion criteria included the neoadjuvant treatment, incomplete resection and no adherence to preoperative guidelines. A total of 359 patients were included in the study. 172 patients were female, and the median age was 68 (61-72). The variables that showed a significant correlation with the upstaging rate at the univariate analysis were the ALK rearrangement, the number of resected lymph nodes and the diameter of the tumor. This result was confirmed in the multivariate analysis, with an OR of 8.052 (CI95% 3.123-20.763, p = 0.00001) for ALK rearrangement, 1.087 (CI95% 1.048-1.127, p = 0.00001) for the number of resected nodes and 1.817 (CI95% 1.214-2.719, p = 0.004) for cT status. Our results showed that in a homogeneous cohort of patients with clinical node early stage LUAD the ALK rearrangement, the number of resected lymph nodes and the tumor diameter can significantly predict nodal metastasis.

Identifiants

pubmed: 37126920
pii: S0169-5002(23)00753-5
doi: 10.1016/j.lungcan.2023.107215
pii:
doi:

Substances chimiques

Receptor Protein-Tyrosine Kinases EC 2.7.10.1
ALK protein, human EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107215

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Filippo Tommaso Gallina (FT)

Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: filippogallina92@gmail.com.

Riccardo Tajè (R)

Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Fabiana Letizia Cecere (F)

Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Daniele Forcella (D)

Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Lorenza Landi (L)

Clinical Trials Center: Phase 1 and Precision Medicine, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Gabriele Minuti (G)

Clinical Trials Center: Phase 1 and Precision Medicine, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Francesca Fusco (F)

Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Simonetta Buglioni (S)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Paolo Visca (P)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Enrico Melis (E)

Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Isabella Sperduti (I)

Biostatistics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Gennaro Ciliberto (G)

Scientific Direction, IRCSS Regina Elena National Cancer Institute, Rome, Italy.

Federico Cappuzzo (F)

Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Francesco Facciolo (F)

Thoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH